Final programme - eshre 2013

P-531 Addition of luteal estradiol pre-treatment in women treated with GnRH antagonist for in vitrofertilization: a systematic review and meta-analysisW. El-khayat, M. Elsadek (Egypt)P-532 pregnancy rate following luteal phase support in polycystic ovarian syndrome using combinationtherapies for ovulation induction: a randomized clinical trialF. Foroozanfard, H. Saberi, A. Moravvegi, M. Kazemi (Iran)P-533 gnRH agonist for triggering final oocyte maturation versus IVM in patients at risk of OHssY.S. Gidoni, A. Raziel, S. Friedler, D. Strassburger, D. Hadari, E. Kasterstein, I. Ben-Ami, D. Komarovsky,B. Maslansky, O. Bern, R. Ron-El (Israel)P-534 should testosterone be used for more patients than only low ovarian respondersM. Pérez Izquierdo, J. Ten, J. Guerrero, F. Araico, J. Llácer, R. Bernabeu (Spain)P-535 ivf outcomes and embryo morphokinetics in women with polycystic ovarian syndromeO. Somova, O. Feskov, I. Feskova, I. Bezpechnaya, I. Zhylkova, O. Tishchenko (Ukraine)P-536 is anti-mullerian hormone (amh) significantly related with hyperandrogenemia or insulin resistance inwomen with pcosS. Kralik Oguic, D. Pavicic Baldani, L. Skrgatic, V. Simunic, H. Vrcic, D. Rogic, J. Juras,M. Sprem Goldstein (Croatia)P-537 experience on the use of Corifollitropin-alfa (Elonva) for controlled ovarian hyperstimulation in ovumdonor cyclesL. Garcia De Miguel, M. Caballero Campo, A. Gurria, J. Alonso, A. Serrano, E. Marbán,P. Caballero Peregrín (Spain)P-538 dysregulation of gene expression in cumulus cells of in vitro matured oocytesA. Hourvitz, L. Shalev, Y. Yung, G. Yerushalmi, C. Giovanni, M. Dal Canto, R. Fadini, J. Has,E. Maman (Israel)P-539 molecular expression of androgen and fsH receptors after follicular priming prior to ICSI cycles -an interim analysis of the "foLLPRIM" randomized controlled trialM. Monterde, R. Gómez, A. Marzal, O. Vega, J.m. Rubio, C. Diaz-Garcia, A. Pellicer (Spain)P-540 Comparison of two strategies to prevent ovarian hyperstimulation syndrome in high-risk patients:GnRH agonist trigger and a 'mild stimulation' regimenA. Eapen, A. Datta, A. Kurinchi-selvan, H. Birch, G.M. Lockwood (United Kingdom)P-541 Clinical preganancy rates of late HCG administration to trigger ovulation in clomiphene citrate induced cylesM.C. Ornek, U. Ates, T. Usta, C.P. Goksedef (Turkey)P-542 the value of I generation AMH measurements kits for prediction of live birth in women undergoingassisted reproductive technologyA. Bruszczynska, J. Glowacka, M. Kunicki, G. Jakiel, T. Wasniewski, K. Jaguszewska, J. Liss,K. Lukaszuk (Poland)P-543 predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlledovarian stimulationS. Oehninger, S. Nelson, P. Verweij, B. Stegmann (U.S.A.)178